RNF7 and prostate carcinoma: As expected, we overexpressed RNF7 in prostate cancer cell lines in combination with YTHDF1 knockdown, which counteracted the inhibitory effect of YTHDF1 knockdown on tumor cell proliferation (Figs. 4M–P, S4E–H).